An observational study to evaluate the efficacy of Agnikarma followed by Bastikarma in Gridhrasi
Abstract
The current lifestyle is the basis for a plethora of diseases. Some are due to the Ahara and some due to Vihara. Gridhrasi is one of the condition mainly lead down by Viharaja. Among the 80 Vataja Nanatmja Vyadhi, Gridhrasi is one of the most common condition. It is a Ruja Pradhana Vatavyadhi i.e., pain is the chief cause for visiting a doctor in most of patient histories, hence it is necessary to adopt fast management for the same. Gridhrasi starts from Sphik Pradesha and gradually comes down to Kati, Prista, Uru, Janu, Janga and Pada. Kevala Vataja and Vata Kaphaja are the two clinical variations in the presentation of Gridhrasi. Snigdha Sweda, Virechana, Basti, Agnikarma and Siravyadha are the Chikitsa mentioned in the classical literature. In the present study, Snigdha Agnikarma followed by Erandamoola Niruha Basti has been adopted. Significant changes (p<0.01) were noticed in the parameters of the study.
Downloads
References
Agnivesha, Charaka, Drudabala, Chakrapanidatta. Chikitsa Sthana, Chapter 28, Verse 57. In: Acharya YT (Edi.), Charaka Samhita with Ayurveda Deepika Commentary. Reprint Edition: 2014. Varanasi: Chaukhamba Surabharathi Prakashana: 2014. p. 619.
Agnivesha, Charaka, Drudabala, Chakrapanidatta. Chikitsa Sthana, Chapter 28, Verse.56-57. In: Acharya YT (Edi.), Charaka Samhita with Ayurveda Deepika Commentary. Reprint Edition: 2014. Varanasi: Chaukhamba Surabharathi Prakashana: 2014. p.619.
Agnivesha, Charaka, Drudabala, Chakrapanidatta. Chikitsa Sthana, Chapter 28, Verse.101. In: Acharya YT (Edi.), Charaka Samhita with Ayurveda Deepika Commentary. Reprint Edition: 2014. Varanasi: Chaukhamba Surabharathi Prakashana: 2014. p.621.
Sushrutha, Dalhana, Gayadasa. SutraSthana, Chapter 12, Verse.13. In: Acharya YT(Edi.), Sushrutha Samhita with Nibandha Sangraha and Nyayachandrika Commentary. Reprint Edition: 2019. Varanasi: Chaukhambha Surabharathi Prakashana: 2019.p.52.
Agnivesha, Charaka, Drudabala, Chakrapanidatta. SiddiSthana, Chapter 3, Verse.17. In: Acharya YT (Edi.), Charaka Samhita with Ayurveda Deepika Commentary. Reprint Edition: 2014. Varanasi: Chaukhamba Surabharathi Prakashana: 2014. p.692 .
Sushrutha, Dalhana, Gayadasa. Chikitsa Sthana, Chapter 37, Verse.58. In: Acharya YT(Edi.), Sushrutha Samhita with Nibandha Sangraha and Nyayachandrika Commentary. Reprint Edition: 2019. Varanasi: Chaukhambha Surabharathi Prakashana: 2019.p.534.
Agnivesha, Charaka, Drudabala, Chakrapanidatta. SiddiSthana, Chapter 3, Verse.17-19. In: Acharya YT (Edi.),Charaka Samhita with Ayurveda Deepika Commentary. Reprint Edition: 2014. Varanasi: Chaukhamba Surabharathi Prakashana: 2014. p.692 .
Sushrutha, Dalhana, Gayadasa. NidhaSthana, Chapter 1, Verse.74. In: Acharya YT(Edi.), Sushrutha Samhita with Nibandha Sangraha and Nyayachandrika Commentary. Reprint Edition: 2019. Varanasi: Chaukhambha Surabharathi Prakashana: 2019.p.268.
Agnivesha, Charaka, Drudabala, Chakrapanidatta. Chikitsa Sthana, Chapter 28, Verse.101. In: Acharya YT (Edi.),Charaka Samhita with Ayurveda Deepika Commentary. Reprint Edition: 2014. Varanasi: Chaukhamba Surabharathi Prakashana: 2014. p.621.
Sushrutha, Dalhana, Gayadasa. Chikitsa Sthana, Chapter 4, Verse.8. In: Acharya YT(Edi.), Sushrutha Samhita with Nibandha Sangraha and Nyayachandrika Commentary. Reprint Edition: 2019. Varanasi: Chaukhambha Surabharathi Prakashana: 2019.p.420.
Dravya guna vijnana, Prof. D. Shanth Kumar Lucaas, First Edition: 2008. Varanasi: Chaukhambha Surabharathi Prakashana: 2008.p. 307, 387
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.